Publicaciones en colaboración con investigadores/as de KU Leuven (19)

2024

  1. Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

    Journal of Osteopathic Medicine

2016

  1. CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation

    American Journal of Human Genetics, Vol. 98, Núm. 2, pp. 310-321

  2. The global spread of HIV-1 subtype B epidemic

    Infection, Genetics and Evolution, Vol. 46, pp. 169-179

2015

  1. Antisense-mediated therapeutic pseudoexon skipping in TMEM165-CDG

    Clinical Genetics, Vol. 87, Núm. 1, pp. 42-48

  2. Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

    PLoS Medicine, Vol. 12, Núm. 4

2012

  1. Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A

    Journal of General Virology, Vol. 93, Núm. 4, pp. 889-899

  2. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

    Retrovirology, Vol. 9

2011

  1. European guidelines on the clinical management of HIV-1 tropism testing

    The Lancet Infectious Diseases, Vol. 11, Núm. 5, pp. 394-407

  2. European recommendations for the clinical use of HIV drug resistance testing: 2011 update

    AIDS Reviews, Vol. 13, Núm. 2, pp. 77-108

2009

  1. Tracing the HIV-1 subtype B mobility in Europe: A phylogeographic approach

    Retrovirology, Vol. 6

2008

  1. Foreword

    AIDS Reviews

2007

  1. Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

    Infection, Genetics and Evolution, Vol. 7, Núm. 3, pp. 382-390

  2. Foreword

    AIDS Reviews

2006

  1. Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent

    Antimicrobial Agents and Chemotherapy, Vol. 50, Núm. 2, pp. 694-701

  2. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    Journal of Acquired Immune Deficiency Syndromes, Vol. 41, Núm. 3, pp. 352-360

2005

  1. Addressing current challenges in haemophilia care: Consensus recommendations of a European Interdisciplinary Working Group

    Haemophilia, Vol. 11, Núm. 5, pp. 433-437

  2. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

    PLoS Medicine, Vol. 2, pp. 0325-0337

  3. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management

    Journal of Infectious Diseases, Vol. 192, Núm. 6, pp. 958-966

2004

  1. Updated European recommendations for the clinical use of HIV drug resistance testing

    Antiviral Therapy, Vol. 9, Núm. 6, pp. 829-848